Japanese Antibacterial Drug Management for Cardiac Sarcoidosis (J‐<scp>ACNES</scp>): A multicenter, open‐label, randomized, controlled study

Abstract

The J-ACNES trial will be the first prospective study assessing the clinical benefit and safety of ABD therapy, in addition to corticosteroid treatment, in patients with CS. Our findings may improve treatment of patients with CS, as additional ABD therapy reduces recurrence of inflammation and elucidates the mechanism of sarcoidosis.